News Articles

Tej Kohli Foundation Seeks to Incubate New Projects That Can Eliminate Corneal Blindness By 2035 LONDON -Monday 24 February 2020  

(BUSINESS WIRE)-- The Tej Kohli Foundation is to establish a new incubator to provide seed and acceleration funding to projects with the potential to help eliminate corneal blindness worldwide. Funding, practical resources and intellectual capital will be available to both commercial and...

Tej Kohli Foundation Moves One Step Closer to the Regeneration of Corneal Tissue to Cure Blindness -Saturday 18 January 2020  

(BUSINESS WIRE) -- The Tej Kohli Foundation has moved one step closer to a non-surgical treatment for corneal blindness as it prepares to enter into a collaboration with researchers in Montreal, Canada and Moorfields Eye Hospital, UK to develop the Foundation’s recently acquired proprietary...

5,736 of the World’s Poorest People Received the Gift of Sight in 2019 at the Tej Kohli Cornea Institute -Saturday 21 December 2019    

(BUSINESS WIRE)-- On the fourth anniversary of the Tej Kohli Cornea Institute in Hyderabad, the Tej Kohli Foundation has renewed its commitment of $14m of funding from 2020. During 2019 5,736 individuals were cured of blindness or severe visual impairment at The Tej Kohli Cornea Institute, which...

Investor Tej Kohli Expands ‘Venture Philanthropy’ Into 3d-printed Bionic Arms -Saturday 30 November 2019  

(BUSINESS WIRE)-- Investor Tej Kohli is to fund the purchase of ten bionic arms for children with limb differences in the UK. The Tej Kohli Foundation hopes that its commitment to fund arms for ten children over the next 5 months as part of its ‘Future Bionics’ program will highlight how...

Tej Kohli Foundation advocates a scalable, accessible and affordable technology solution to end corneal blindness... -Thursday 10 October 2019    

(BUSINESS WIRE)-- On World Sight Day, the Tej Kohli Foundation says that a focus on new technologies is needed to accelerate the global mission to end curable corneal blindness worldwide. The Foundation is currently funding the clinical trials and development of a ‘liquid biosynthetic’...